References and Notes
1a
Arakawa H.
Aresta M.
Armor JN.
Barteau MA.
Beckman EJ.
Bell AT.
Bercaw JE.
Creutz C.
Dinjus E.
Dixon DA.
Domen K.
Dubois DL.
Eckert J.
Fujita E.
Gibson DH.
Goddard WA.
Goodman DW.
Keller J.
Kubas GJ.
Kung HH.
Lyons JE.
Manzer LE.
Marks TJ.
Morokuma K.
Nicholas KM.
Periana R.
Que L.
Rostrup-Nielson J.
Sachtler WMH.
Schmidt LD.
Sen A.
Somorjai GA.
Stair PC.
Stults BR.
Tumas W.
Chem. Rev.
2001,
101:
953
1b
Beckman EJ.
Ind. Eng. Chem. Res.
2003,
42:
1598
1c
Shi M.
Shen Y.-M.
Curr. Org. Chem.
2003,
7:
737
2
Darensbourg DJ.
Holtcamp MW.
Coord. Chem. Rev.
1996,
153:
155
3a
Matsumoto K.
Fuwa S.
Kitajima H.
Tetrahedron Lett.
1995,
36:
6499
3b
Chang H.-T.
Sharpless KB.
Tetrahedron Lett.
1996,
37:
3219
3c
Shaikh A.-AG.
Sivaram S.
Chem. Rev.
1996,
96:
951
3d
Biggadike K.
Angell RM.
Burgess CM.
Farrell RM.
Hancock AP.
Harker AJ.
Irving WR.
Ioannou C.
Procopiou PA.
Shaw RE.
Solanke YE.
Singh OMP.
Snowden MA.
Stubbs RJ.
Walton S.
Weston HE.
J. Med. Chem.
2000,
43:
19
4a
Nomura R.
Ninagawa A.
Matsuda H.
J. Org. Chem.
1980,
45:
3735
4b
Kihara N.
Hara N.
Endo T.
J. Org. Chem.
1993,
58:
6198
4c
Yano T.
Mastsui H.
Koike T.
Ishigure H.
Fujihara H.
Yoshihara M.
Maeshima T.
Chem. Commun.
1997,
1129
4d
Yamaguchi K.
Ebitani K.
Yoshida T.
Yoshida H.
Kaneda K.
J. Am. Chem. Soc.
1999,
121:
4526
4e
Kawanami H.
Ikushima Y.
Chem. Commun.
2000,
2089
4f
Kim HS.
Kim JJ.
Lee BG.
Jung OS.
Jang HG.
Kang SO.
Angew. Chem. Int. Ed.
2000,
39:
4096
4g
Paddock RL.
Nguyen ST.
J. Am. Chem. Soc.
2001,
123:
11498
4h
Caló V.
Nacci A.
Monopoli A.
Fanizzi A.
Org. Lett.
2002,
4:
2561
4i
Sako T.
Fukai T.
Sahashi R.
Ind. Eng. Chem. Res.
2002,
41:
5353
4j
Shen Y.-M.
Duan W.-L.
Shi M.
J. Org. Chem.
2003,
68:
1559
4k
Shen Y.-M.
Duan W.-L.
Shi M.
Adv. Synth. Catal.
2003,
345:
337
4l
Paddock RL.
Hiyama Y.
Mckay JM.
Nguyen ST.
Tetrahedron Lett.
2004,
45:
2023
4m
Shen Y.-M.
Duan W.-L.
Shi M.
Eur. J. Org. Chem.
2004,
3080
4n
Alvaro M.
Baleizao C.
Das D.
Carbonell E.
García H.
J. Catal.
2004,
228:
254
4o
Li F.
Xiao L.
Xia C.
Hu B.
Tetrahedron Lett.
2004,
45:
8307
4p
Paddock RL.
Nguyen ST.
Chem. Commun.
2004,
1622
4q
Jiang J.-L.
Gao F.
Hua R.
Qiu X.
J. Org. Chem.
2005,
70:
381
4r
Sit WN.
Ng SM.
Kwong KY.
Lau CP.
J. Org. Chem.
2005,
70:
8583
4s
Mori K.
Mitani Y.
Hara T.
Mizugaki T.
Ebitani K.
Kaneda K.
Chem. Commun.
2005,
3331
4t
Xie H.
Duan H.
Li S.
Zhang S.
New J. Chem.
2005,
29:
1199
4u
Du Y.
Wang J.-Q.
Chen J.-Y.
Cai F.
Tian J.-S.
Kong D.-L.
He L.-N.
Tetrahedron Lett.
2006,
47:
1271
5
Typical Experimental Procedure: Propylene oxide (20 mmol), l-phenylalanine (0.16 mmol) and CH2Cl2 (1 mL) were added into a 15 mL stainless autoclave with a magnetic stirrer, and CO2 (liquid, 3.2 MPa) was charged into the reactor at r.t. The initial pressure was generally adjusted to 6 MPa at 130 °C. The autoclave was heated at that temperature for 48 h, and the pressure was kept constant during the reaction. After the reaction, the reactor was cooled to 0 °C, and extra CO2 was vented slowly. The crude product was analyzed by a gas chromatograph, compared with authentic sample, and the yields were determined by GC using tridecane as internal standard. The crude product (yield: 100% by GC) was purified by distillation and propylene carbonate was obtained in 93% isolated yield. The cyclic carbonate was identified by IR, GC/MS (HP6890/5973) and 400 MHz NMR spectroscopy.
6 Spectroscopic data of the cyclic carbonates:
4-Methyl-1,3-dioxolan-2-one (2a): IR (neat): 1795 (C=O) cm-1. MS (EI): m/z = 102 [M+]. 1H NMR (400 MHz, TMS, CDCl3): δ = 1.48 (d, J = 3.6 Hz, 3 H, CH3), 4.01 (t, J = 8.4 Hz, 1 H, CH), 4.53 (t, J = 8.0 Hz, 1 H, CH), 4.81-4.86 (m, 1 H, CH).
4-Chloromethyl-1,3-dioxolan-2-one (2b): IR (neat): 1790 (C=O) cm-1. MS (EI): m/z = 136 [M+]. 1H NMR (400 MHz, TMS, CDCl3): δ = 3.72-3.74 (m, 2 H, CH2), 4.38 (q, J = 6.0 Hz, 1 H, CH), 4.57 (t, J = 8.4 Hz, 1 H, CH), 4.91-4.94 (m, 1 H, CH).
4-Phenyl-1,3-dioxolan-2-one (2c): IR (neat): 1816 (C=O) cm-1. MS (EI): m/z = 164 [M+]. 1H NMR (400 MHz, TMS, CDCl3): δ = 4.31-4.35 (m, 1 H, CH), 4.76-4.82 (m, 1 H, CH), 5.66 (t, J = 8.0 Hz, 1 H, CH), 7.32-7.44 (m, 5 H, C6H5).
4-Butyl-1,3-dioxolan-2-one (2d): IR (neat): 1798 (C=O) cm-1. MS (EI): m/z = 145 [M+]. 1H NMR (400 MHz, TMS, CDCl3): δ = 0.91 (t, J = 4.8 Hz, 3 H, CH3), 1.32-1.38 (m, 4 H, CH2), 1.65-1.78 (m, 2 H, CH2), 4.04 (dd, J = 7.2, 8.4 Hz, 1 H, CH), 4.50 (t, J = 8.0 Hz, 1 H, CH), 4.64-4.71 (m, 1 H, CH).
4-Phenoxymethyl-1,3-dioxolan-2-one (2e): IR (neat): 1796 (C=O) cm-1. MS (EI): m/z = 194 [M+]. 1H NMR (400 MHz, TMS, CDCl3): δ = 4.13 (dd, J = 3.6, 10.4 Hz, 1 H, CH), 4.22 (dd, J = 4.0, 10.4 Hz, 1 H, CH), 4.52 (dd, J = 6.0, 8.8 Hz, 1 H, CH), 4.60 (t, J = 4.4 Hz, 1 H, CH), 4.99-5.02 (m, 1 H, CH), 6.89 (d, J = 7.6 Hz, 2 H, Ph), 7.00 (t, J = 7.6 Hz, 1 H, Ph), 7.29 (dd, J = 7.6, 8.4 Hz, 2 H, Ph).
4-Allyloxymethyl-1,3-dioxolan-2-one (2f): IR (neat): 1796 (C=O) cm-1. MS (EI): m/z = 159 [M+ + H]. 1H NMR (400 MHz, TMS, CDCl3): δ = 3.21-3.68 (m, 2 H, CH2), 4.02-4.04 (m, 2 H, CH2), 4.37 (dd, J = 6.0, 8.4 Hz, 1 H, CH), 4.48 (t, J = 8.4 Hz, 1 H, CH), 4.75-4.80 (m, 1 H, CH), 5.18-5.28 (m, 2 H, CH2), 5.81-5.87 (m, 1 H, CH).
Cyclohexyl-1,3-dioxolan-2-one (2g): IR (neat): 1801 (C=O) cm-1. MS (EI): m/z = 142 [M+]. 1H NMR (400 MHz, TMS, CDCl3): δ = 1.37-1.41 (m, 2 H, CH2), 1.57-1.61 (m, 2 H, CH2), 1.85-1.89 (m, 4 H, CH2), 4.63-4.68 (m, 2 H, CH).
7a
Rokicki A.
Kuran W.
J. Macromol. Sci., Rev. Macromol. Chem.
1981,
C21:
135
7b
Darensbourg DJ.
Yarbrough JC.
J. Am. Chem. Soc.
2002,
124:
6335
7c
Darensbourg DJ.
Billodeaux DR.
Inorg. Chem.
2005,
44:
1433
8a
Bonaccorsi R.
Palla P.
Tomasi J.
J. Am. Chem. Soc.
1984,
106:
1945
8b
Furic K.
Mohacek V.
Bonifacic M.
Stefanic I.
J. Mol. Struct.
1992,
267:
39
8c
Jensen JH.
Gordon MS.
J. Am. Chem. Soc.
1995,
117:
8159
8d
Kemp DS.
Vellaccio F.
Organic Chemistry
Worth Publishers, Inc.;
New York:
1980.
p.1007
9a
Baldwin JE.
J. Chem. Soc., Chem. Commun.
1976,
734
9b
Baldwin JE.
Cutting J.
Dupont W.
Kruse L.
Silberman L.
Thomas RC.
J. Chem. Soc., Chem. Commun.
1976,
736